National conference on prostate cancerMURPHY, Gerald.Cancer. 1995, Vol 75, Num 7, issn 0008-543X, 282 p., SUPConference Proceedings

Chemoprevention for prostate cancerBRAWER, M. K; ELLIS, W. J.Cancer. 1995, Vol 75, Num 7, pp 1783-1789, issn 0008-543X, SUPConference Paper

Prostatic cryotherapy : current experiencesLITTRUP, P. J; SPARSCHU, R. A; GRIGNON, D et al.Cancer. 1995, Vol 75, Num 7, pp 1957-1962, issn 0008-543X, SUPConference Paper

Prostate cancer : an overview of an increasing dilemmaCOFFEY, D. S.Cancer. 1993, Vol 71, Num 3, pp 880-886, issn 0008-543X, SUPConference Paper

Basis for hormonal management of advanced prostate cancerGELLER, J.Cancer. 1993, Vol 71, Num 3, pp 1039-1045, issn 0008-543X, SUPConference Paper

Conservative approaches to the management of localized prostatic cancerWHITMORE, W. F.Cancer. 1993, Vol 71, Num 3, pp 970-975, issn 0008-543X, SUPConference Paper

Screening and early detection of prostate cancerCHODAK, G. W.Cancer. 1993, Vol 71, Num 3, pp 981-983, issn 0008-543X, SUPConference Paper

Prostate cancer groups : help, information, supportCALABRESE, D. A.Cancer. 1995, Vol 75, Num 7, pp 1897-1899, issn 0008-543X, SUPConference Paper

Frontiers in prostate cancer : telomeres and chaosSOMMERFELD, H. J; MEEKER, A. K; POSADAS, E. M et al.Cancer. 1995, Vol 75, Num 7, pp 2027-2035, issn 0008-543X, SUPConference Paper

Management of hormonal treatment effectsKIRSCHENBAUM, A.Cancer. 1995, Vol 75, Num 7, pp 1983-1986, issn 0008-543X, SUPConference Paper

Management of stage T1c prostate cancerGIBBONS, R. P.Cancer. 1995, Vol 75, Num 7, pp 1900-1902, issn 0008-543X, SUPConference Paper

Sexual rehabilitation of the prostate cancer patientSPROUSE, D. O.Cancer. 1995, Vol 75, Num 7, pp 1954-1956, issn 0008-543X, SUPConference Paper

Adjuvant therapy for localized prostate cancerSCHMIDT, J. D; GIBBONS, R. P; MURPHY, G. P et al.Cancer. 1993, Vol 71, Num 3, pp 1005-1013, issn 0008-543X, SUPConference Paper

Endocrine therapy of advanced carcinoma of the prostateDANESHGARI, F; CRAWFORD, E. D.Cancer. 1993, Vol 71, Num 3, pp 1089-1097, issn 0008-543X, SUPConference Paper

Molecular genetics and chromosomal alterations in prostate cancerISAACS, W. B; BOVA, G. S; MORTON, R. A et al.Cancer. 1995, Vol 75, Num 7, pp 2004-2012, issn 0008-543X, SUPConference Paper

Ketoconazole and liarozole in the treatment of advanced prostatic cancerMAHLER, C; VERHELST, J; DENIS, L et al.Cancer. 1993, Vol 71, Num 3, pp 1068-1073, issn 0008-543X, SUPConference Paper

Oncogene in prostate cancer : an updtatePEEHL, D. M.Cancer. 1993, Vol 71, Num 3, pp 1159-1164, issn 0008-543X, SUPConference Paper

Radiaton therapy for localized diseaseBAGSHAW, M. A; KAPLAN, I. D; COX, R. C et al.Cancer. 1993, Vol 71, Num 3, pp 939-952, issn 0008-543X, SUPConference Paper

Sexual rehabilitation after treatment for prostate cancerSCHOVER, L. R.Cancer. 1993, Vol 71, Num 3, pp 1024-1030, issn 0008-543X, SUPConference Paper

The diagnosis of prostatic carcinomaBRAWER, M. K.Cancer. 1993, Vol 71, Num 3, pp 899-905, issn 0008-543X, SUPConference Paper

Epidemiologic characteristics of prostate cancerGIOVANNUCCI, E.Cancer. 1995, Vol 75, Num 7, pp 1766-1777, issn 0008-543X, SUPConference Paper

Prostate specific antigen role and functionPEEHL, D. M.Cancer. 1995, Vol 75, Num 7, pp 2021-2026, issn 0008-543X, SUPConference Paper

A pathologist's view of prostatic carcinomaMOSTOFI, F. K; SESTERHENN, I. A; DAVIS, C. J et al.Cancer. 1993, Vol 71, Num 3, pp 906-932, issn 0008-543X, SUPConference Paper

Antiandrogenic agents as monotherapy in advanced prostatic carcinomaSOLOWAY, M. S; MATZKIN, H.Cancer. 1993, Vol 71, Num 3, pp 1083-1088, issn 0008-543X, SUPConference Paper

Expanding the definition of quality of life for prostate cancerSHARP, J. W.Cancer. 1993, Vol 71, Num 3, pp 1078-1082, issn 0008-543X, SUPConference Paper